No, it’s not true. Low-testosterone (Low-T) lawsuits have been classified as a mass tort lawsuit and a federal judge has ordered that these lawsuits proceed in what is called multi-district litigation (MDL). In MDL, each person brings their own case and has their own attorney, but all the cases claiming the same injuries against the same manufacturers are heard by one federal judge.
Some individual lawsuits have already been filed in federal courts around the country and many more people will probably file lawsuits soon. A person can also file a suit in state court, but it may be removed to a federal district court in some circumstances.
There are over 14 different drugs to treat Low-T which are manufactured by different pharmaceutical companies. Here is a short list of the most-prescribed drugs and their manufacturers:
- Androderm – Watson Pharmaceuticals
- AndroGel – AbbieVie, Division of Abbot Laboratories
- Axiron – Eli Lilly
- Delatestryl – Endo Pharmaceutical Solutions, Inc.
- Fortesta – Endo Pharmaceuticals Solutions, Inc.
- Methitest – Global Pharmaceuticals, Division of Impax Laboratories Inc.
- Striant – Actient Pharmaceuticals; Columbia Laboratories, Inc.
- Testim – Auxilium Pharmaceuticals, Inc.
- Testopel – Auxilium Pharmaceuticals, Inc., Bartor Pharmacal (marketed by Slate Pharma)
- Testred – Valeant Pharmaceuticals North America LLC
If you took one of these Low-T medications and suffered a heart attack or stroke, you should consider talking to a personal injury attorney about the possibility of bringing a lawsuit against the pharmaceutical company that manufactured your prescription drug.